Evidence map›Paper›PMID 39268408›Full record

ReviewBiomedical reports2024

Advances in antibacterial activity of zinc oxide nanoparticles against

Yuqing Hao, Yadong Wang, Li Zhang, Fang Liu, Yuefei Jin, Jinzhao Long, Shuaiyin Chen, Guangcai Duan, Haiyan Yang

Abstract readReview
In one paragraph

Review in Biomedical reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Veterinary sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuqing HaoDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Yadong WangDepartment of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, P.R. China.
Li ZhangDepartment of Infectious diseases, Xinyang Center for Disease Control and Prevention, Xinyang, Henan 464000, P.R. China.
Fang LiuDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Yuefei JinDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Jinzhao LongDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Shuaiyin ChenDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Guangcai DuanDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Haiyan YangDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) are one of the promising strategies to deal with bacterial infections. As the main subset of NPs, metal and metal oxide NPs show destructive power against bacteria by releasing metal ions, direct contact of cell membranes and antibiotic delivery. Recently, a number of researchers have focused on the antibacterial activity of zinc oxide nanoparticles (ZnO NPs) against

Indexed as

antibacterial activityStaphylococcus aureuszinc oxide nanoparticles

Identifiers

PMID39268408
PMCPMC11391181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.